Jay S. Duker - 01 Nov 2022 Form 4 Insider Report for EyePoint Pharmaceuticals, Inc. (EYPT)

Role: Chief Operating Officer
Signature: /s/ Ron Honig, Attorney-in-Fact
Issuer symbol: EYPT
Transactions as of: 01 Nov 2022
Net transactions value: -$24,276
Form type: 4
Filing time: 03 Nov 2022, 08:38:31 UTC
Previous filing: 09 Sep 2022
Next filing: 10 Jan 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EYPT	Common Stock	Options Exercise	$0	+15,258	+144%	$0.000000	25,881	01 Nov 2022	Direct
transaction	EYPT	Common Stock	Tax liability	$24,276	-4,479	-17%	$5.42	21,402	01 Nov 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	EYPT	Restricted Stock Units	Options Exercise	$0	-15,258	-100%	$0.000000^*	0	01 Nov 2022	Common Stock	15,258	$0.000000	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units
F2	Fully vested on the one-year anniversary of the grant date.